Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- James E. Besser
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 51
- Beta
- 0.07
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -17.74
Financials
Net Income
$-6.49MEBITDA
$-5.99MFree Cash Flow
$-6.66MEPS (diluted)
$-1.19Shares Outstanding (diluted)
5.45M+39159.7%Operating Expenses
$3.18MCash & Debt
$3.92MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $0.00 | $-28.24M | $-12.36 |
| 2025 | $0.00 | $-18.82M | $-15.30 |
| 2024 | $0.00 | $-17.47M | $-23.40 |
| 2023 | $0.00 | $-13.88M | $-38.40 |
| 2022 | $0.00 | $-18.63M | $-82.20 |
| 2021 | $0.00 | $-7.38M | $-35.70 |
| 2020 | $0.00 | $-5.32M | $-26.70 |
| 2019 | $0.00 | $-2.54M | $-13.80 |
| 2018 | $0.00 | $-659.2K | $-4.50 |
| 2017 | $0.00 | $-106.6K | $-2.74 |
| 2016 | $0.00 | $-31.1K | $-2.24 |
| 2015 | $0.00 | $-31.0K | $-2.23 |
| 2014 | $0.00 | $-22.8K | $-1.64 |
| 2013 | $0.00 | $-20.8K | $-1.50 |
Valuation
MODDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
90-25.00%Social Signal Score
Mentions (2)
- Newsbenzinga.com·6h ago·Negative
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades Modular Medical, Inc. (NASDAQ:MODD) on Thursday announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system.
View source ↗ - Newsaccessnewswire.com·1d ago·Positive
Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026 Meet with Modular Medical CEO Jeb Besser. Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period.
View source ↗
Earnings
Wed, Dec 2(in 3 months)
Typical surprise -9.5% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Jun 29$-1.37 vs $-2.70beat
- Tue, Feb 17$-3.30 vs $-3.00miss
- Fri, Nov 14$-0.14 vs $-0.10miss
- Thu, Aug 14$-0.12 vs $-0.10miss
- Fri, Jun 20$-0.12 vs $-0.11miss
- Thu, Feb 13$-0.13 vs $-0.12miss
Estimates and results for MODD via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by MODD officers and directors.
- Bought
- $2.8m
- Sold
- —
7 trades
0 trades
- Manchester Management Co Llcboughtdirector, 10 percent owner, officer, other: Chief Executive Officer·520,832 @ $1.92·$1000k·Mar 20, 2025·filing
- Manchester Management Co Llcboughtdirector, 10 percent owner, officer, other: Chief Executive Officer·156,250 @ $1.92·$300k·Mar 20, 2025·filing
- Manchester Management Co Llcbought
- Manchester Management Co Llcbought
- Manchester Management Co Llcbought
- Sheibley Philip Brentbought
- Manchester Management Co Llcboughtdirector, 10 percent owner, other: Director by Deputization·900,000 @ $1.10·$990k·Feb 16, 2024·filing
93 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.